Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials

Published:2023-01-02 Issue:8 Volume:112 Page:1044-1055
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Carvalho Pedro E. P.^ORCID,Veiga Thiago M. A.,Simões e Silva Ana C.,Gewehr Douglas M.,Dagostin Caroline S.,Fernandes Amanda,Nasi Guilherme,Cardoso Rhanderson

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00392-022-02148-2.pdf

Reference44 articles.

1. Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K et al (2020) Acute heart failure. Nat Rev Dis Primers. https://doi.org/10.1038/S41572-020-0151-7

2. Sinnenberg L, Givertz MM (2020) Acute heart failure. Trends Cardiovasc Med 30:104–112. https://doi.org/10.1016/J.TCM.2019.03.007

3. Testani JM, ter Maaten JM (2016) Decongestion in acute heart failure: does the end justify the means? JACC Heart Fail 4:589–590. https://doi.org/10.1016/J.JCHF.2016.03.024

4. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:E895-1032. https://doi.org/10.1161/CIR.0000000000001063

5. Rubio-Gracia J, Demissei BG, ter Maaten JM, Cleland JG, O’Connor CM, Metra M et al (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185–191. https://doi.org/10.1016/J.IJCARD.2018.01.067

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-09-11

2. Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study;BMC Cardiovascular Disorders;2024-08-02

3. Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: CON;Kidney360;2024-08

4. Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes;World Journal of Diabetes;2024-07-15

5. SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure;Renal Failure;2024-07-05